| Inflammatory bowel disease (IBD)/CROHN’S | Cytotoxicity and proliferation assays |
| Pro and anti-inflammatory marker studies |
| Gut microbiome analysis by NGS |
| Host–microbiome interactions and pathways |
| Measurement of ALP, ZO-1, MMP2, MMP9, MUC2, MUC5AC, and ADAMTS1 |
| |
| Stem Cells Research for Degenerative Diseases | Isolation and Characterization |
| Isolation and maintenance of adult tissues and umbilical cord blood/tissue-derived stem cells. |
| Characterization of MSCs/AMSCs/HSCs/NSCs by flow cytometry |
| 2D and 3D model-based Differentiation Studies |
| Neuronal Differentiation Studies |
| Osteogenic Differentiation Studies |
| Adipogenic Differentiation Studies |
| Cardiomyocytes Differentiation Studies |
| Dendritic and other immune cell generation from HSCs/MSCs |
| Trans-differentiation studies |
| Signalling pathways governing stem cells: Notch, Wnt, Hedgehog etc |
| |
| Wound Healing | Proliferation assays |
| Cell migration assays: Scratch and cell inserts based |
| Angiogenesis assays: Tube formation assay, CAM assay |
| Anti-inflammatory assays: Pro and Anti-inflammatory cytokines studies |
| |
| Endocrine Disruption Screening | Estrogen Receptor (ER) Transactivation |
| Androgen Receptor (AR) Transactivation |
| Androgen Receptor (AR) Modulation |
| Estrogen Receptor-alpha (ER-α) Binding |
| Estrogen Receptor beta (ER-β) Binding |
| Androgen Receptor (AR) Binding |
| Steroidogenesis |
| Aromatase Assay |
| Miscellaneous based on customers requirement subject to Feasibility |
| |
